After-Hours Stock Movers 01/22: (SLM) (EYE) (PTC) Higher; (PRA) (IMGN) (AVNW) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
PTC Inc. (PTC) PT Raised to $95 at Mizuho Securities
January 23, 2020 7:52 AM ESTMizuho Securities analyst Matthew Broome raised the price target on PTC Inc. (NASDAQ: PTC) to $95.00 (from $80.00) while maintaining a Buy rating.
The analyst commented, "PTC reported a very positive start to FY20 with upside to ARR, revenue, and EPS, and management... More
Xenon Pharmaceuticals (XENE) Prices 3.75M Share Common Offering at $16/Sh
January 23, 2020 5:50 AM ESTXenon Pharmaceuticals Inc. (NASDAQ: XENE), a clinical stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,750,000 common shares pursuant to its existing shelf registration statement at a public offering price of $16.00 per share. The gross proceeds to Xenon from the offering,... More
Immunogen (IMGN) Prices 21.325M Share Common Offering at $4.25/Sh
January 23, 2020 5:49 AM ESTImmunoGen, Inc., (NASDAQ:... More

